Abstract: A method for processing medical data, an apparatus and a storage medium, the method includes: acquiring a case-history datum, and performing a target process to obtain a disease-analysis vector, wherein the target process includes: generating a case-history semantic vector of the case-history datum; for each of preset diseases in a preset-disease set, determining a first possibility weight of the case-history datum caused by the preset disease according to the case-history semantic vector, to obtain a first weight vector; according to case-history symptoms and case-history diseases in the case-history datum, determining from a predetermined knowledge graph a candidate disease that is capable of generating generate the case-history datum; determining a second possibility weight of the case-history datum caused by the candidate disease, to obtain a second weight vector; and fusing the first weight vector and the second weight vector, to obtain the disease-analysis vector corresponding to the case-history datum.

Abstract: The present disclosure relates to a collection device and a preparation system, including a pre-adjustment mechanism which is disposed in a housing and configured to adjust at least one bundle of carbon nanotube aggregates, and includes a first pre-adjustment sub-mechanism and a second pre-adjustment sub-mechanism for adjusting carbon nanotube aggregations along a first direction and a second direction, respectively; a winding mechanism for winding and collecting the carbon nanotube aggregates passing through the pre-adjustment mechanism.

Abstract: The present application discloses a recombinant Newcastle disease virus genome, a recombinant Newcastle disease virus rNDV-VEGF-Trap containing the genome and a preparation method therefor, a DNA molecule encoding the recombinant Newcastle disease virus genome, and a use of the genome and the recombinant Newcastle disease virus in the preparation of a drug for treating cancer. The recombinant Newcastle disease virus provided by the present application relates to inserting a coding gene of VEGF-Trap into the genome of the recombinant Newcastle disease virus, such that the recombinant Newcastle disease virus obtained therefrom is replicated with a strong replication capability, thereby killing host cancer cells; moreover, the recombinant Newcastle disease virus has reliable safety for non-cancer cells, and shows improved anti-tumor effect and oncolytic efficiency.

Abstract: Provided are an electrokinetic device and method for in-situ leaching of uranium, belonging to the technical field of in-situ leaching of uranium. The electrokinetic device for in-situ leaching of uranium includes an injection well, a pumping well, a positive electrode, a negative electrode, leaching solution, and a direct current power supply. Uranium ore is provided between the injection well and the pumping well, the negative electrode is arranged in the injection well, and the positive electrode is arranged in the pumping well. The leaching solution is injected from the injection well, flows through the uranium ore, and then is pumped from the pumping well for uranium extraction. The direct current power supply is respectively connected to the positive electrode and the negative electrode, and is configured to apply direct current between the positive electrode and the negative electrode to promote the pooling of uranium-carrying ions towards the pumping well.

Abstract: A method of controlling intra prediction for decoding or encoding of a video sequence, is performed by at least one processor and includes obtaining intra prediction modes including directional modes respectively corresponding to angular prediction directions, a first amount of one or more of the directional modes being excluded from the intra prediction modes based on a second amount of the intra prediction modes and a third amount of most probable modes (MPMs). The method further includes selecting, as the MPMs, two or more of the intra prediction modes from which the one or more of the directional modes are excluded, and selecting, for decoding the video sequence, one of the intra prediction modes from which the one or more of the directional modes are excluded.

Abstract: An apparatus for video decoding includes receiving and processing circuitry. The circuitry is configured to receive a bitstream including a syntax element associated with a parent coding unit (CU) in a picture indicating the parent CU is partitioned into a predefined set of child CUs without performing a recursive tree-structure-based partitioning, and process the child CUs according to the indication of the syntax element to reconstruct the picture. In an embodiment, at least two subdivisions need to be performed when the parent CU is partitioned using the recursive tree-structure-based partitioning in order to obtain the same set of child CUs. In an embodiment, at least one of the child CUs has a size larger than a minimum allowed CU size for partitioning the parent CU and includes no syntax element to indicate whether the at least one of the child CUs is to be further subdivided.

Abstract: A data decoding method, performed by a computer device, is provided. The data decoding method includes obtaining coded data corresponding to a current to-be-decoded unit, obtaining a coding mode restriction type corresponding to the current to-be-decoded unit by decoding the coded data, determining a candidate coding mode set corresponding to the current to-be-decoded unit according to the coding mode restriction type, the candidate coding mode set comprising a block copy intra-frame coding mode, selecting a target coding mode from the candidate coding mode set, and decoding the current to-be-decoded unit according to the target coding mode, thereby obtaining corresponding decoded data.

Abstract: Provided are an apparatus (1) for dispensing viscous fluid and a method for dispensing viscous fluid with the same. The apparatus (1) comprises: a support structure (2) adapted to receive a plurality of cartridges (41, 42); and a plurality of push rods (31, 32) and a transmission means (7) that are mounted to the support structure (2), each push rod being configured to be translatable in a longitudinal direction thereof. The transmission means (7) is configured to receive a driving force from a power source and transmit the driving force to the plurality of push rods (31, 32) at different transmission ratios so as to translate the plurality of push rods at different speeds.

Abstract: A tube connector made from a polyamide composition, the polyamide composition including at least one first polyamide A having an average number of carbon atoms per nitrogen atom CA and at least one second polyamide B having an average number of carbon atoms per nitrogen atom CB, wherein CA?8.5 and CB?7.5, and wherein CA<CB. The composition may include a third polyamide C having an average number of carbon atoms per nitrogen atom CC, wherein CB?CC.

Abstract: A method for identifying an individual of an oplegnathus punctatus based on a convolutional neural network is provided. Target initial positioning involves three continuous convolutional layers and an average pooling layer. A region of feature interest point is obtained, a hyperparameter candidate box is set to obtain a region, thereby obtaining an approximate position of a target object. II_Net backbone convolutional neural network includes six convolutional layers and four pooling layers, which includes a LeakyReLU activation function used as an activation function of the first convolutional layer, convolutional network layers of Alexnet and parameter data, and a maximum pooling layer of an overlapped pooling structure. Fully connected layers use a genetic algorithm to improve data transmission between layers. With the established model, identification of the individual of the oplegnathus punctatus is performed by using test data.

Abstract: Disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, W, n are defined as in the present application. Also disclosed is a method for treating cancer, comprising administering to a subject in need thereof a therapeutically effective amount of the compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The compound and a salt thereof according to the present application possess good anticancer and/or antitumor activity, and good water solubility and stability, as well as good tolerance in animal bodies. Also disclosed is a process for preparing a compound represented by formula (I) of the present application.

Abstract: A tube connector made from a polyamide composition, the polyamide composition including at least one first polyamide A having an average number of carbon atoms per nitrogen atom CA and at least one second polyamide B having an average number of carbon atoms per nitrogen atom CB, wherein CA?8.5 and CB?7.5, and wherein CA<CB. The composition may include a third polyamide C having an average number of carbon atoms per nitrogen atom CC, wherein CB?CC.

Abstract: Disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, W, n are defined as in the present application.

Abstract: Disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, W, n are defined as in the present application. Also disclosed is a method for treating cancer, comprising administering to a subject in need thereof a therapeutically effective amount of the compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The compound and a salt thereof according to the present application possess good anticancer and/or antitumor activity, and good water solubility and stability, as well as good tolerance in animal bodies. Also disclosed is a process for preparing a compound represented by formula (I) of the present application, comprising reacting a compound represented by formula (II) with a compound represented by formula (III) in the presence of a condensation agent to obtain a compound represented by formula (I).

Abstract: Disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, W, n are defined as in the present application.

Abstract: A tube connector made from a polyamide composition, the polyamide composition including at least one first polyamide A having an average number of carbon atoms per nitrogen atom CA and at least one second polyamide B having an average number of carbon atoms per nitrogen atom CB, wherein CA?8.5 and CB?7.5, and wherein CA<CB. The composition may include a third polyamide C having an average number of carbon atoms per nitrogen atom CC, wherein CB?CC.

Abstract: A gasket for a battery, wherein the gasket is made from a polyamide composition including at least 70 wt. % of a polyamide X.Y, wherein X and Y represent respective residues from the condensation of an aliphatic diamine comprising 4 to 18 carbon atoms, and preferably 5 to 12 carbon atoms, with a (cyclo)aliphatic diacid including 10 to 18 carbon atoms, and wherein the polyamide composition further includes a nucleating agent.

Abstract: A monofilament made from a polyamide composition including at least 70 wt. % of a polyamide resulting from the condensation of: an aliphatic diamine having 4 to 18 carbon atoms, together with a (cyclo)aliphatic diacid having 10 to 18 carbon atoms, and with an aliphatic monocarboxylic acid having 2 to 12 carbon atoms as a chain stopping agent. Also, a process for making this monofilament.